MD(General Medicine)@GMCNagpur|DM(Nephrology) @OffCMCVellore|ESENeph|@GlomCon Glomerular Disease Fellow 2025|@NephJC Intern 2026
Vellore, India
Joined April 2019
- Tweets563
- Following2.2K
- Followers369
- Likes2.4K
S M Assad retweeted
Your research may be one of the best 👍
Share your work at #ISNWCN
Last 2 days for submission
Get connected
Don’t miss on networking and research opportunities
Let’s work towards strengthening global kidneycare
@ISNWCN @ISNkidneycare
💬 “I am very excited to get the award as well as to attend WCN for the first time. It is a wonderful experience for me. So many people is gathered here.
There are networking and research opportunities.”
— Shanjida Sharmim, WCN'26 Fellowship Best Abstract Award winner
🌍 Share your research at #ISNWCN.
📅 Submit by October 28: bit.ly/4b4Iipk #Nephrology #KidneyResearch
S M Assad retweeted
@LauraDember presenting about
Pragmatic Trials: the evolving landscape
#kidneywk
📍 Historically, nephrology trials have been small and highly selective: 66% were single-center and 65% enrolled fewer than 100 participants. Traditional trials often operate separately from routine care, limiting generalizability and increasing complexity
S M Assad retweeted
#kidneywk Day 3 of simultaneous publications covered by #nephjc
Until the next time 👋
✍️@CristinaDeReins @dra_miliflores @DrAkshayaJ @hswapnil @brian_rifkin @kidney_boy
nephjc.com/news/denver-day3
S M Assad retweeted
📢🫘 October 2026 issue of #NDT is out!
🔬 Podocytopathies & kidney organoids
🦴 CKD-associated osteoporosis
🧬 Kidney genetics
💉 Rituximab in membranous nephropathy
📊 CKD burden
🔗 academic.oup.com/ndt/issue/4… 🆕
#Nephrology @NDTsocial
S M Assad retweeted
⏩First trial in today’s LBCT session #kidneywk
📍 ATTACK Trial | Aspirin for primary cardiovascular prevention in CKD
👉CKD increases cardiovascular risk, but whether aspirin offers a net benefit for primary prevention remains uncertain
👉In the general population, aspirin modestly reduces major vascular events (11% relative reduction) but increases major bleeding (43%), with little absolute net benefit
👉ATTACK is a pragmatic, multicentre, open-label RCT comparing aspirin 75 mg daily with usual care in adults with CKD stages 1–4, without established CV disease or increased bleeding risk
S M Assad retweeted
#nephjc coverage of #kidneywk simultaneous publications day 1✨✨
✍️By @hswapnil @DrAkshayaJ @CristinaDeReins @dra_miliflores
nephjc.com/news/2026/10/21/k…
S M Assad retweeted
🚨 One of the most anticipated nights of #KidneyWk is almost here!
Come celebrate 15 years of #NephJC Nights with friends, colleagues, food, drinks, and plenty of kidney conversations.
📍 Denver Press Club
📅 Friday, October 23
Good company 💙
nephjc.com/news/2026/9/13/th…
S M Assad retweeted
1/ Kidney stones #KidneyWk
🪨 hyperechoic foci with posterior acoustic shadowing
🪨Color Doppler may reveal a twinkling artifact, improving stone detection
🪨Common obstruction sites: ureteropelvic junction, iliac vessel crossing, and ureterovesical junction
🪨Smaller stones are more likely to pass spontaneously
@JaberiAala
S M Assad retweeted
✅ Renal POCUS: SECONDS checklist #KidneyWk
@JaberiAala @NephroP
✅A systematic approach to kidney ultrasound:
☑️S – Size: Assess kidney length and cortical thickness.
☑️E – Echogenicity: Compare renal cortex with the liver or spleen
☑️C – Collecting system: Look for hydronephrosis and urinary tract dilation
☑️O – Outline: Check renal contours for irregularities or masses
☑️N – Notable lesions: Identify cysts, stones, or focal abnormalities
☑️D – Doppler: Assess renal perfusion and vascular abnormalities
☑️S – Surroundings: Look for perinephric collections or other adjacent abnormalities
S M Assad retweeted
Position paper on the importance of POCUS in nephrology published in @CKJsocial #kidneywk
@NephroP @nephrothaniel
🔗 academic.oup.com/ckj/article…
S M Assad retweeted
💥Whatever your passion in nephrology, @isn_india’s ISNCON 2026 @ISNCONkochi2026 has a place for YOU!
🏥From career development sessions and 💰financial planning tips for young nephrologists to research guidance, courses on interventional nephrology, clinical trials, kidney health disparities, dialysis, transplant, Glomerulonephritis, and the whole width and breadth of nephrology AND beyond, there’s something for everyone!
🌍 Join us to learn from inspiring national and international speakers, explore new ideas, and connect with the nephrology community.
And as a bonus, you’ll get to enjoy the scenic beauty and amazing cuisines of Kerala 🍛🏖️⛱️
What’s NOT to love ? ❤️
Come be a part of the excitement. We can’t wait to welcome you! 🎉
@drshyambansal @arvindcanchi
@thisis_drgsp
@melgreux
@KKNephBytes
@drshahinnephro
@DrSouravSarkar3
@ShreshtaT
@taruna_pahuja
@YashenduSarda
S M Assad retweeted
#GNchat tomorrow
Topic is MPGN, organized and hidden deposits
When: Oct 20, 2026 08:00 AM Eastern Time (US and Canada)
Register in advance for this meeting:
northwell.zoom.us/meeting/re…
@purvasharma821 @HofstraKidney @ISGDtweets
S M Assad retweeted
Before #kidneywk starts: among 76 severe pregnancy-associated TMA referrals, not a single case was classified as confirmed inaugural aHUS
✨Underdiagnosis, overdiagnosis avoided, or a new way of thinking about obstetric TMA?
👇More on @KIReports blog
kireportscommunity.org/post/…
S M Assad retweeted
If there is one thing you read from my account, let this be it !!
It’s a tribute to my dear friend, soul sister and someone whose loss I’ll never be able to overcome. 💔
Let the world know my dear friend, Dr Kedara Gowri, MD Internal Medicine (PGI Chandigarh), DM Nephrology (JIPMER Pondicherry), loving daughter, a friend who’s family, traveller, artist and a beautiful person inside out ❤️ !!
akshayanephro.substack.com/p…
S M Assad retweeted
The focused update of the KDIGO 2027 CKD Guideline is available for public review through November 4, 2026.
KDIGO invites the global kidney community to review the draft and share feedback to help inform and improve the final update.
Visit the KDIGO CKD Guideline website to download the draft and share your comments via the feedback survey:
kdigo.org/guidelines/ckd-eva…
The focused update addresses new evidence since publication of the KDIGO 2024 CKD Guideline on SGLT2 inhibitors, GLP-1-based therapies, and nsMRAs in people with CKD, excluding those receiving dialysis or who have received a kidney transplant.
Thank you for your time and insights.
S M Assad retweeted
🩺 Dialysis Troubleshooting Series | Intradialytic Hypotension
Why does BP drop during hemodialysis?
Is it just excessive ultrafiltration, or is there more to it?
💡 Treat the mechanism, not just the BP!
Clinical question in the comments- Do reply ✌️
S M Assad retweeted
Did you know that #NephjC is on Instagram?
We turn most of the featured studies into a visual summary in just 6-7 images. Check out the latest one ✨
By @AncaSt13 & @CristinaDeReins
nephjc.com/news/2026/ig/tran…
S M Assad retweeted
CMC Quality Improvement Project titled 'Phased Implementation of the Surgical Safety Care Bundle' was awarded Winner in the Quality Improvement category at the BMJ Awards South Asia 2026, held last month in New Delhi.
The project was presented by Dr. Lallu Joseph, Quality Manager, CMC Vellore, who received the award on behalf of the institution during the award ceremony.
This prestigious recognition acknowledges the collective efforts and commitment of the multidisciplinary teams from Surgery, Anaesthesia, Operation Theatre Nursing, and the Quality Management Cell (QMC) in enhancing #PatientSafety and quality of #SurgicalCare through the successful implementation of the Surgical Safety Care Bundle. The award is a testament to the institution’s continued pursuit of excellence in #PatientCare and #QualityImprovement initiatives.
